Nomura Holdings Inc Invitae Corp Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $132,702 - $228,517	-4,014 Reduced 6.8%	55,055 $2.11 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $153,115 - $224,835	3,917 Added 7.1%	59,069 $2.47 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $1.57 Million - $2.46 Million	55,152 New	55,152 $2.4 Million
Q2 2020 Aug 14, 2020	SELL	$11.71 - $30.29 $177,207 - $458,378	-15,133 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $39,216 - $141,157	5,133 Added 51.33%	15,133 $208,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $188,500 - $275,000	10,000 New	10,000 $183,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.